{"id":"W4385666975","doi":"10.1097/01.hs9.0000970432.75766.0c","title":"P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE 2 MM-014 STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; Thames Valley Children's Centre; Princess Margaret Cancer Centre; McGill University Health Centre; University of Calgary","funders":"","keywords":"Lenalidomide; Pomalidomide; Daratumumab; Medicine; Internal medicine; Multiple myeloma; Cohort; Dexamethasone; Regimen; Clinical endpoint; Oncology; Gastroenterology; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002210197,0.000791179,0.001302052,0.000382028,0.0003066726,0.001132251,0.0007483528,0.0008141145,0.002943035],"category_scores_gemma":[0.001212388,0.0003500665,0.002211015,0.0004703852,0.0003624136,0.0007502114,0.0007265678,0.001678773,0.0004968468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008758039,"about_ca_system_score_gemma":0.001095737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007954096,"about_ca_topic_score_gemma":0.002172501,"domain_scores_codex":[0.9993357,0.000368634,0.00003940771,0.00009887711,0.00006368674,0.00009362924],"domain_scores_gemma":[0.9991868,0.0001199802,0.0002806631,0.00006134337,0.00005425452,0.0002970855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7961965,0.009030157,0.1097088,0.0009355224,0.006770209,0.0001881191,0.0001876481,0.002006565,0.004894098,0.0001840693,0.006787364,0.06311101],"study_design_scores_gemma":[0.4420391,0.2463563,0.2867231,0.0002843769,0.008401865,0.0006070086,0.0002570329,0.002489672,0.002107227,0.0005644485,0.01008826,0.00008155021],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928543,0.002651076,0.00012436,0.0004531077,0.00006963816,0.0004739247,0.002357655,0.00002684588,0.0009892432],"genre_scores_gemma":[0.9907668,0.001050575,0.0003786407,0.0005954716,0.0001860794,0.0006867203,0.004974744,0.00001245739,0.001348567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002943035,"threshold_uncertainty_score":0.01168877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04037242643722707,"score_gpt":0.3232737664310684,"score_spread":0.2829013399938414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}